Completed
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
NCT00406315
- Conditions
- Mental Disorders, Psychotic Disorders, Schizoaffective Disorder, +2 more
- Locations
-
- Pfizer Investigational Site Phoenix, Arizona, United States
- Pfizer Investigational Site Costa Mesa, California, United States
- Pfizer Investigational Site Garden Grove, California, United States
- Pfizer Investigational Site National City, California, United States